FDA Inspection 1219574 — Qilu Pharmaceutical Hulun Buir Branch
The FDA completed an inspection of Qilu Pharmaceutical Hulun Buir Branch on August 25, 2023 in Hulun Buir. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Hulun Buir (China)